tiprankstipranks
Lytix Biopharma AS (DE:6BG)
FRANKFURT:6BG
Germany Market
6BG
Lytix Biopharma AS
RESEARCH TOOLSreports

Lytix Biopharma AS (6BG) Financial Statements

3 Followers

Lytix Biopharma AS Financial Overview

Lytix Biopharma AS's market cap is currently €57.63M. The company's EPS TTM is €-1.67; its P/E ratio is -6.23; Lytix Biopharma AS is scheduled to report earnings on August 27, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 0.00kr 11.13Mkr 3.99Mkr 11.03Mkr 19.31M
Gross Profitkr -1.00Mkr -23.46Mkr 3.99Mkr 11.03Mkr 19.31M
Operating Incomekr -68.65Mkr -95.90Mkr -96.78Mkr -65.67Mkr -47.98M
EBITDAkr -63.02Mkr -93.22Mkr -86.88Mkr -54.91Mkr -47.56M
Net Incomekr -59.98Mkr -94.27Mkr -87.90Mkr -56.07Mkr -48.08M
Balance Sheet
Cash & Short-Term Investmentskr 72.36Mkr 130.79Mkr 48.98Mkr 143.78Mkr 197.28M
Total Assetskr 81.52Mkr 146.53Mkr 63.87Mkr 153.27Mkr 202.96M
Total Debtkr 3.42Mkr 2.64Mkr 492.00Kkr 1.34Mkr 0.00
Net Debtkr -7.18Mkr -128.15Mkr -25.30Mkr -91.83Mkr -197.28M
Total Liabilitieskr 19.77Mkr 38.64Mkr 12.55Mkr 18.23Mkr 13.34M
Stockholders' Equitykr 61.75Mkr 107.89Mkr 51.32Mkr 135.03Mkr 189.62M
Cash Flow
Free Cash Flowkr -59.85Mkr -70.37Mkr -96.02Mkr -52.78Mkr -44.61M
Operating Cash Flowkr -57.53Mkr -70.37Mkr -95.97Mkr -52.63Mkr -44.61M
Investing Cash Flowkr -61.76Mkr 24.69Mkr 29.73Mkr -49.35Mkr 138.00K
Financing Cash Flowkr -901.00Kkr 149.10Mkr -943.00Kkr -749.00Kkr 213.30M
Currency in NOK

Lytix Biopharma AS Earnings and Revenue History

Income Statement >

Lytix Biopharma AS Debt to Assets

Balance Sheet >

Lytix Biopharma AS Cash Flow

Cash Flow >

Lytix Biopharma AS Forecast EPS vs Actual EPS

Earnings >